Literature DB >> 17614124

What a polyclonal antibody sees in von Willebrand factor.

Fen-Lai Tan1, David Ginsburg.   

Abstract

INTRODUCTION: Von Willebrand factor (VWF) plays a critical role in hemostasis by carrying factor VIII (FVIII) and binding to specific ligands on the surface of blood platelets and within the blood vessel wall.
MATERIALS AND METHODS: We constructed a gene-specific phage display library containing small, random VWF fragments. Using this library, we mapped the repertoire of immune epitopes recognized by a commonly used commercial rabbit antihuman VWF polyclonal antibody.
RESULTS: A total of eight discrete epitopes within the VWF protein were identified, including two dominant epitopes that account for 74% of immuno selected VWF fragments. Comparison with previously mapped epitopes for mouse monoclonal antibodies reveals four overlapping regions that may identify common antigenic determinants. The distribution of these epitopes was not readily predicted from primary amino acid sequence divergence among these mammalian species or standard algorithms for the prediction of antigenicity, hydrophobicity, or surface probability.
CONCLUSION: Taken together with previous monoclonal antibody epitope mapping studies, our results suggest that a limited number of exposed domains on the surface of the human VWF protein may be the primary determinants of immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614124      PMCID: PMC2258224          DOI: 10.1016/j.thromres.2007.05.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  26 in total

1.  Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.

Authors:  M De Luca; D A Facey; E J Favaloro; M S Hertzberg; J C Whisstock; T McNally; R K Andrews; M C Berndt
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

Review 2.  Interactions between von Willebrand factor and Factor VIII: where did they first meet.

Authors:  R R Montgomery; J C Gill
Journal:  J Pediatr Hematol Oncol       Date:  2000 May-Jun       Impact factor: 1.289

Review 3.  Protein-protein interactions in hematology and phage display.

Authors:  B P Mullaney; M G Pallavicini
Journal:  Exp Hematol       Date:  2001-10       Impact factor: 3.084

4.  An immuno-precipitation assay for determining specific interactions between antibodies and phage selected from random peptide expression libraries.

Authors:  T A M A Al-bukhari; P Tighe; I Todd
Journal:  J Immunol Methods       Date:  2002-06-01       Impact factor: 2.303

Review 5.  Phage display for epitope determination: a paradigm for identifying receptor-ligand interactions.

Authors:  Merrill J Rowley; Karen O'Connor; Lakshmi Wijeyewickrema
Journal:  Biotechnol Annu Rev       Date:  2004

Review 6.  Molecular genetics of type 2 von Willebrand disease.

Authors:  Edith Fressinaud; Claudine Mazurier; Dominique Meyer
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain.

Authors:  E N van den Brink; E A Turenhout; C M Bank; K Fijnvandraat; M Peters; J Voorberg
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

9.  Localization of von willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis.

Authors:  T Matsushita; D Meyer; J E Sadler
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

10.  Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.

Authors:  Eric G Huizinga; Shizuko Tsuji; Roland A P Romijn; Marion E Schiphorst; Philip G de Groot; Jan J Sixma; Piet Gros
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

View more
  4 in total

1.  Blocking von Willebrand factor for treatment of cutaneous inflammation.

Authors:  Carina Hillgruber; Annika K Steingräber; Birgit Pöppelmann; Cécile V Denis; Jerry Ware; Dietmar Vestweber; Bernhard Nieswandt; Stefan W Schneider; Tobias Goerge
Journal:  J Invest Dermatol       Date:  2013-06-28       Impact factor: 8.551

2.  Functional display of platelet-binding VWF fragments on filamentous bacteriophage.

Authors:  Andrew Yee; Fen-Lai Tan; David Ginsburg
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

3.  Phage display broadly identifies inhibitor-reactive regions in von Willebrand factor.

Authors:  Andrew Yee; Manhong Dai; Stacy E Croteau; Jordan A Shavit; Steven W Pipe; David Siemieniak; Fan Meng; David Ginsburg
Journal:  J Thromb Haemost       Date:  2021-07-28       Impact factor: 16.036

4.  Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF.

Authors:  Matthias F Schneider; Mohammad A Fallah; Christian Mess; Tobias Obser; Reinhard Schneppenheim; Alfredo Alexander-Katz; Stefan W Schneider; Volker Huck
Journal:  BMC Mol Cell Biol       Date:  2020-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.